BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155 | -17.1% | 4,109 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $187 | +8.7% | 4,109 | -3.0% | 0.00% | 0.0% |
| Q1 2023 | $172 | -22.5% | 4,234 | -2.9% | 0.00% | -25.0% |
| Q4 2022 | $222 | -99.9% | 4,359 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $235,000 | -24.2% | 4,359 | -9.6% | 0.00% | -20.0% |
| Q2 2022 | $310,000 | -23.6% | 4,821 | -8.0% | 0.01% | -16.7% |
| Q1 2022 | $406,000 | -13.1% | 5,241 | -3.7% | 0.01% | 0.0% |
| Q4 2021 | $467,000 | +6.6% | 5,441 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $438,000 | 0.0% | 5,441 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $438,000 | -17.4% | 5,441 | -13.4% | 0.01% | -25.0% |
| Q1 2021 | $530,000 | -26.0% | 6,286 | -29.5% | 0.01% | -27.3% |
| Q4 2020 | $716,000 | -3.6% | 8,918 | -3.5% | 0.01% | -21.4% |
| Q3 2020 | $743,000 | -6.7% | 9,245 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $796,000 | +7.9% | 9,245 | +1.6% | 0.02% | -11.1% |
| Q1 2020 | $738,000 | -7.6% | 9,095 | -4.8% | 0.02% | +50.0% |
| Q4 2019 | $799,000 | -4.1% | 9,558 | +0.3% | 0.01% | -7.7% |
| Q3 2019 | $833,000 | +14.1% | 9,525 | +6.9% | 0.01% | +18.2% |
| Q2 2019 | $730,000 | +0.7% | 8,911 | 0.0% | 0.01% | +10.0% |
| Q1 2019 | $725,000 | +44.1% | 8,911 | +16.6% | 0.01% | +25.0% |
| Q4 2018 | $503,000 | -16.7% | 7,641 | -2.6% | 0.01% | 0.0% |
| Q3 2018 | $604,000 | +4.3% | 7,841 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $579,000 | +13.5% | 7,841 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $510,000 | +0.6% | 7,841 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $507,000 | -0.6% | 7,841 | -3.6% | 0.01% | 0.0% |
| Q3 2017 | $510,000 | +3.7% | 8,131 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $492,000 | +16.6% | 8,131 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $422,000 | +16.9% | 8,131 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $361,000 | -23.7% | 8,131 | -18.2% | 0.01% | -28.6% |
| Q3 2016 | $473,000 | +3.3% | 9,936 | -2.0% | 0.01% | 0.0% |
| Q2 2016 | $458,000 | -45.3% | 10,136 | -50.4% | 0.01% | 0.0% |
| Q1 2016 | $838,000 | +109.0% | 20,422 | +94.5% | 0.01% | 0.0% |
| Q4 2015 | $401,000 | +13.9% | 10,499 | -2.0% | 0.01% | 0.0% |
| Q3 2015 | $352,000 | -63.0% | 10,717 | -21.2% | 0.01% | -58.8% |
| Q2 2015 | $952,000 | -10.4% | 13,608 | -12.3% | 0.02% | -5.6% |
| Q1 2015 | $1,063,000 | -16.1% | 15,513 | -10.3% | 0.02% | -25.0% |
| Q4 2014 | $1,267,000 | -4.0% | 17,288 | -6.0% | 0.02% | -7.7% |
| Q3 2014 | $1,320,000 | +0.1% | 18,388 | +0.8% | 0.03% | 0.0% |
| Q2 2014 | $1,319,000 | -80.8% | 18,248 | -80.5% | 0.03% | -83.2% |
| Q1 2014 | $6,887,000 | +4.5% | 93,602 | -1.2% | 0.16% | +0.6% |
| Q4 2013 | $6,590,000 | +5.2% | 94,757 | -0.7% | 0.15% | +13.2% |
| Q3 2013 | $6,266,000 | -3.8% | 95,386 | +1.5% | 0.14% | -3.5% |
| Q2 2013 | $6,513,000 | – | 94,021 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |